You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (11) |
Back to Search
THE FOLLOW-UP EVALUATION OF ADVERSE DRUG REACTION REPORTING CASES IN A MEDICAL CENTER
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-HPS-072
- By: LIN, Jhao-Yi (Shin Kong Wu Ho-Su Memorial Hospital, Pharmacy, China Taiwan)
- Co-author(s): Jhao-Yi Lin: Department of pharmacy, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, China Taiwan
Yi-Chang Wu: Department of pharmacy, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, China Taiwan
Chun-Yu Wang: Department of pharmacy, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, China Taiwan - Abstract:
Background
Due to the limited data on adverse reactions before drug enters into the market, healthcare professionals should be encouraged to actively report Adverse Drug Reactions (ADRs) once a drug is marketed. The National Adverse Drug Reactions Reporting System set up by the Drug Relief Foundation reports the ADR reporting process in Taiwan.Metho..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026